SI2112153T1 - Postopek za zmanjšanje alfa, beta-nenasičenih ketonov v opioidnih sestavkih - Google Patents

Postopek za zmanjšanje alfa, beta-nenasičenih ketonov v opioidnih sestavkih

Info

Publication number
SI2112153T1
SI2112153T1 SI200630885T SI200630885T SI2112153T1 SI 2112153 T1 SI2112153 T1 SI 2112153T1 SI 200630885 T SI200630885 T SI 200630885T SI 200630885 T SI200630885 T SI 200630885T SI 2112153 T1 SI2112153 T1 SI 2112153T1
Authority
SI
Slovenia
Prior art keywords
beta
unsaturated ketones
reducing alpha
opioid compositions
reducing
Prior art date
Application number
SI200630885T
Other languages
English (en)
Inventor
Robert Joe Kupper
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of SI2112153T1 publication Critical patent/SI2112153T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
SI200630885T 2005-03-04 2006-02-27 Postopek za zmanjšanje alfa, beta-nenasičenih ketonov v opioidnih sestavkih SI2112153T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65879105P 2005-03-04 2005-03-04
EP09158939A EP2112153B1 (en) 2005-03-04 2006-02-27 Method of reducing alpha, beta- unsaturated ketones in opioid compositions

Publications (1)

Publication Number Publication Date
SI2112153T1 true SI2112153T1 (sl) 2011-02-28

Family

ID=36301669

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200630344T SI1861405T1 (sl) 2005-03-04 2006-02-27 Postopek za zmanjšanje alfa,beta-nenasičenih ketonov v opioidnih sestavkih
SI200630885T SI2112153T1 (sl) 2005-03-04 2006-02-27 Postopek za zmanjšanje alfa, beta-nenasičenih ketonov v opioidnih sestavkih

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI200630344T SI1861405T1 (sl) 2005-03-04 2006-02-27 Postopek za zmanjšanje alfa,beta-nenasičenih ketonov v opioidnih sestavkih

Country Status (19)

Country Link
US (1) US7939543B2 (sl)
EP (2) EP2112153B1 (sl)
JP (1) JP5314894B2 (sl)
KR (1) KR100941761B1 (sl)
CN (1) CN101133062B (sl)
AT (2) ATE487722T1 (sl)
CA (1) CA2598774C (sl)
CY (2) CY1109262T1 (sl)
DE (2) DE602006018208D1 (sl)
DK (2) DK2112153T3 (sl)
ES (2) ES2355870T3 (sl)
HK (2) HK1111695A1 (sl)
HR (2) HRP20090387T1 (sl)
ME (2) ME01594B (sl)
PL (2) PL2112153T3 (sl)
PT (2) PT2112153E (sl)
RS (2) RS51131B (sl)
SI (2) SI1861405T1 (sl)
WO (1) WO2006094672A1 (sl)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US20070048228A1 (en) * 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
MXPA06001452A (es) * 2003-08-06 2007-04-02 Gruenenthal Chemie Forma de administracion a prueba de abuso.
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
TWI483944B (zh) 2004-03-30 2015-05-11 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US8871779B2 (en) * 2006-03-02 2014-10-28 Mallinckrodt Llc Process for preparing morphinan-6-one products with low levels of α,β-unsaturated ketone compounds
AU2007329453B2 (en) * 2006-12-04 2013-04-04 Noramco, Llc Process for preparing oxycodone having reduced levels of 14-hydroxycodeinone
ES2378710T3 (es) 2006-12-04 2012-04-17 Noramco, Inc. Procedimiento para reducir impurezas en la base de oxicodona
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
CA2684458A1 (en) * 2007-04-16 2008-10-30 Mallinckrodt Inc. Novel opiate reduction utilizing catalytic hydrogen transfer reaction
FR2923484B1 (fr) * 2007-11-09 2012-11-09 Sanofi Aventis Procede de preparation de composes morphiniques
JP5774853B2 (ja) 2008-01-25 2015-09-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 医薬投薬形
JP5607550B2 (ja) * 2008-03-11 2014-10-15 ディポメド，インコーポレイティド 非オピオイド鎮痛剤及びオピオイド鎮痛剤の組合せを含む胃保持性持続放出剤形
US8372432B2 (en) 2008-03-11 2013-02-12 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
WO2009135680A1 (en) 2008-05-09 2009-11-12 Grünenthal GmbH Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
AU2010275755B2 (en) * 2009-07-22 2014-04-24 Grünenthal GmbH Oxidation-stabilized tamper-resistant dosage form
CA2765971C (en) * 2009-07-22 2017-08-22 Gruenenthal Gmbh Hot-melt extruded controlled release dosage form
WO2011026125A2 (en) * 2009-08-31 2011-03-03 Depomed, Inc. Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
US8597681B2 (en) 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US9198861B2 (en) 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
EP2377866B1 (en) * 2010-03-23 2014-02-26 Siegfried AG Preparation of low impurity opiates in a continuous flow reactor
TWI471289B (zh) 2010-06-11 2015-02-01 Rhodes Technologies 使三級胺進行ｎ－脫烷反應之方法
CA2802295C (en) 2010-06-11 2016-09-20 Rhodes Technologies Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
EP2611426B1 (en) 2010-09-02 2014-06-25 Grünenthal GmbH Tamper resistant dosage form comprising inorganic salt
PL2611425T3 (pl) 2010-09-02 2014-09-30 Gruenenthal Gmbh Odporna na ingerencję postać dawki zawierająca polimer anionowy
US8658631B1 (en) 2011-05-17 2014-02-25 Mallinckrodt Llc Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
HUE034710T2 (hu) 2011-07-29 2018-02-28 Gruenenthal Gmbh Visszaéléssel szemben ellenálló, azonnali hatóanyagfelszabadulást biztosító tabletta
PT2736495T (pt) 2011-07-29 2017-11-30 Gruenenthal Gmbh Comprimido resistente à adulteração proporcionando libertação imediata de fármaco
WO2013127831A1 (en) 2012-02-28 2013-09-06 Grünenthal GmbH Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
MX362357B (es) 2012-04-18 2019-01-14 Gruenenthal Gmbh Forma de dosificacion farmaceutica resistente a la adulteracion y resistente a la liberacion inmediata de la dosis.
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
EP2970320B1 (en) * 2013-03-15 2020-10-28 Johnson Matthey Public Limited Company Morphine sulfate methanolic solvate, processes for making same and related compositions and methods for treating pain
EP3003283A1 (en) 2013-05-29 2016-04-13 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
JP6449871B2 (ja) 2013-07-12 2019-01-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング エチレン−酢酸ビニルポリマーを含有する改変防止剤形
WO2015078891A1 (en) 2013-11-26 2015-06-04 Farmaceutici Formenti S.P.A. Preparation of a powdery pharmaceutical composition by means of cryo-milling
US9062062B1 (en) 2013-12-18 2015-06-23 Cody Laboratories, Inc. Synthesis of oxycodone hydrochloride
US8846923B1 (en) 2013-12-18 2014-09-30 Cody Laboratories, Inc. Preparation of 14-hydroxycodeinone sulfate
US10227354B2 (en) 2013-12-18 2019-03-12 Cody Laboratories, Inc. Conversion of oxycodone base to oxycodone hydrochloride
CN106572980A (zh) 2014-05-12 2017-04-19 格吕伦塔尔有限公司 包含他喷他多的防篡改即释胶囊制剂
EP3148512A1 (en) 2014-05-26 2017-04-05 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping
MA40332A (fr) 2014-07-09 2021-04-28 Rhodes Tech Réduction des niveaux de cétone alpha, beta-insaturée dans des compositions de dérivés de morphinane
EP3285745A1 (en) 2015-04-24 2018-02-28 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3812312A (en) * 1971-11-15 1974-05-21 Chrysler Corp Impact velocity sensor switch with linearly movable controller
US5869669A (en) * 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
GB9713703D0 (en) 1997-06-30 1997-09-03 Johnson Matthey Plc Preparation of opiates
US6177567B1 (en) * 1999-10-15 2001-01-23 Boehringer Ingelheim Chemicals, Inc. Method for preparing oxycodone
TWI483944B (zh) * 2004-03-30 2015-05-11 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝

Also Published As

Publication number Publication date
KR20070108931A (ko) 2007-11-13
PT2112153E (pt) 2010-12-17
KR100941761B1 (ko) 2010-02-11
JP5314894B2 (ja) 2013-10-16
PL1861405T3 (pl) 2009-10-30
SI1861405T1 (sl) 2009-10-31
DK2112153T3 (da) 2011-02-14
EP2112153A1 (en) 2009-10-28
PL2112153T3 (pl) 2011-04-29
CN101133062B (zh) 2014-08-06
ATE487722T1 (de) 2010-11-15
ME01184B (me) 2013-03-20
HRP20090387T1 (en) 2009-08-31
DE602006006558D1 (de) 2009-06-10
US20080132702A1 (en) 2008-06-05
EP2112153B1 (en) 2010-11-10
ES2326491T3 (es) 2009-10-13
EP1861405B1 (en) 2009-04-29
CA2598774C (en) 2010-12-21
RS51131B (sr) 2010-10-31
DE602006018208D1 (de) 2010-12-23
CN101133062A (zh) 2008-02-27
ATE430153T1 (de) 2009-05-15
CA2598774A1 (en) 2006-09-14
ES2355870T3 (es) 2011-03-31
RS51568B (en) 2011-08-31
JP2008531626A (ja) 2008-08-14
ME01594B (me) 2014-09-20
HK1135107A1 (en) 2010-05-28
WO2006094672A1 (en) 2006-09-14
DK1861405T3 (da) 2009-07-20
HRP20110078T1 (hr) 2011-03-31
US7939543B2 (en) 2011-05-10
EP1861405A1 (en) 2007-12-05
CY1111241T1 (el) 2015-06-11
HK1111695A1 (en) 2008-08-15
PT1861405E (pt) 2009-07-27
CY1109262T1 (el) 2014-07-02

Similar Documents

Publication Publication Date Title
HK1135107A1 (en) Method of reducing alpha, beta- unsaturated ketones in opioid compositions
MX2008010921A (es) Procesos para preparar productos de morfinan-6-ona con bajos niveles de compuestos de cetona alfa, beta-insaturados.
MY155418A (en) Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
TW200736256A (en) Process for the preparation of substituted heterocycles
EP1938892A4 (en) SOLID DEOXYGENANT COMPOSITION AND METHOD FOR MANUFACTURING THE SAME
NZ602862A (en) Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
WO2011060304A3 (en) Oxygen scavengers, compositions comprising the scavengers, and artcles made from the compositions
WO2009117676A3 (en) Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase
MX2010004195A (es) Trans-clomifeno para el sindrome metabolico.
IL227565A (en) Salts of hexahydropananthridine preserved in position 5 of the heterocyclic group and pharmaceutical preparations containing them
DK2044067T3 (da) Fremgangsmåde til fremstilling af 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octanbromid
TW200700071A (en) Novel use
MX2011008885A (es) Composiciones, sintesis y metodos para usar derivados de arilpiperazina.
EP1942170A4 (en) ACCELERATORS FOR OZONE OXIDATION, OZONE OXIDIZING COMPOUND COMPOSITION, AND OZONE PROCESSING
WO2009154993A8 (en) Compositions, synthesis, and methods of using piperazine based antipsychotic agents
ATE452117T1 (de) Verfahren zur herstellung von cyclischen ketonen
DK2038341T3 (da) Sammensætning med en polymer og en oxidationskatalysator
MX2011006845A (es) Inhibidores de glyt1 biciclicos 3.1.0 y metodos para elaboracion y utilizacion de los mismos.
ATE511760T1 (de) Nuss-stückchen enthaltendes kaugummi
EP2305803A4 (en) THERMOSTABLE 1,5-ANHYDROGLUCITOL DEHYDROGENASE AND METHOD OF MEASURING 1,5-ANHYDROGLUCITOL USING THE SAME
WO2009112709A3 (fr) Nouveau procede pour la preparation d'extraits de ginkgo biloba
WO2008011161A3 (en) Dermal anesthetic compounds
MX2009003200A (es) Procedimiento para la preparacion de pradofloxacino.
UA40760U (ru) Состав для защиты металлов от коррозии